Biomason

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatment for people with life-threatening disorders. The company s wholly owned subsidiary, Talecris Plasma Resources, is a national network of plasma collection centers that provides the source material for the production of critical care protein therapies. Talecris Biotherapeutics employs more than 4,300 people worldwide. The company is licensed to do in-house nucleic acid testing for hepatitis C, hepatitis B and human immunodeficiency virus. It offers aseptic filling, plasma fractionation and pharmaceutical compounding, as well as extraction, concentration and purification services for complex molecules. Talecris Biotherapeutics sponsors external research grant programs.

Cellex, Inc, based in Durham, NC, is a leading provider of rapid COVID-19 detection solutions for medical professionals. Their FDA EUA authorized Cellex qSARS-CoV-2 IgG IgM Rapid Test delivers test results in as little as 15 minutes, helping to save lives with highly accurate antigen and antibody detection. Offering the first FDA EUA authorized COVID-19 antibody test, Cellex's portable blood draw test detects IgM and IgG antibodies to identify past COVID-19 infections. With a focus on research, screening, and surveillance, Cellex's innovative lateral flow technology ensures rapid and reliable results for medical professionals and organizations.Generated from the website

Xilis Inc, based in Durham, NC, is revolutionizing precision oncology and drug development with their MicroOrganoSphereTM (MOS) technology. Developed by world-class scientists, their platform enables rapid diagnostics for personalized therapy prioritization, high-throughput drug discovery, and patient-centric solutions for cancer drug development. With their Precision Oncology Platform, Xilis empowers clinicians to make informed treatment decisions by predicting patient response and guiding optimal therapeutic options. Their breakthrough technology provides cost-effective screening, personalized assays, and companion diagnostics to guide patients to newly developed treatments.Generated from the website